![Enzymes / Integrase / Microbiology / Virology / ViiV Healthcare / Intel Viiv / Shionogi / Dolutegravir / HIV / Integrase inhibitors / Biology / Organofluorides Enzymes / Integrase / Microbiology / Virology / ViiV Healthcare / Intel Viiv / Shionogi / Dolutegravir / HIV / Integrase inhibitors / Biology / Organofluorides](https://www.pdfsearch.io/img/97d3adc47fc6c54010acb9a2355d8fcc.jpg)
| Document Date: 2014-11-03 11:26:18 Open Document File Size: 45,28 KBShare Result on Facebook
City Osaka / Glasgow / London / / Company ViiV Healthcare / Shionogi & Co. Ltd. / Corporate Communications Shionogi & Co. Ltd. / / Country United Kingdom / Japan / / Event FDA Phase / / / IndustryTerm foreign healthcare reforms / with respect to product / / MedicalCondition HIV Infection / / MedicalTreatment Drug Therapy / / Organization International Congress / / Person Isao Teshirogi / Dominique Limet / / / Position President & CEO / Chief Executive Officer / / Product Integrase Inhibitor / SPRING-2 / /
SocialTag |